IGSBvsIHE
iShares 1-5 Year Investment Grade Corporate Bond ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGSB | IHE | |
|---|---|---|
| Expense ratio | 0.040% | 0.40% |
| Assets | $23.3B | $1.6B |
| Net flow, 1 month | +$135M | −$14M |
| Net flow, 1 year | +$2.6B | +$756M |
| Return, YTD | -3.2% | +15.9% |
| Return, 1 year | -3.2% | +30.5% |
| Avg daily volume | 5.3M | 204K |
| Holdings | 3892 | 38 |
| Listed | Jan 5, 2007 | May 1, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS